The Preventive and Curative Effects of Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 on Immobilization Stress-Induced Anxiety/Depression and Colitis in Mice
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
The gut dysbiosis by stressors such as immobilization deteriorates psychiatric disorders through microbiota-gut-brain axis activation. To understand whether probiotics could simultaneously alleviate anxiety/depression and colitis, we examined their effects on immobilization stress (IS)-induced anxiety/depression and colitis in mice. The probiotics Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 were isolated from healthy human feces. Mice with anxiety/depression and colitis were prepared by IS treatment. NK33 and NK98 potently suppressed NF-κB activation in lipopolysaccharide (LPS)-induced BV-2 cells. Treatment with NK33 and/or NK98, which were orally gavaged in mice before or after IS treatment, significantly suppressed the occurrence and development of anxiety/depression, infiltration of Iba1+ and LPS+/CD11b+ cells (activated microglia) into the hippocampus, and corticosterone, IL-6, and LPS levels in the blood. Furthermore, they induced hippocampal BDNF expression while NF-κB activation was suppressed. NK33 and/or NK98 treatments suppressed IS-induced colon shortening, myeloperoxidase activity, infiltration of CD11b+/CD11c+ cells, and IL-6 expression in the colon. Their treatments also suppressed the IS-induced fecal Proteobacteria population and excessive LPS production. They also induced BDNF expression in LPS-induced SH-SY5Y cells in vitro. In conclusion, NK33 and NK98 synergistically alleviated the occurrence and development of anxiety/depression and colitis through the regulation of gut immune responses and microbiota composition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Oral administration of Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 attenuated IS-induced anxiety/depression and hippocampal inflammation in mice. (A) Procedure. Effects on anxiety/depression-like behaviors in elevated plus maze (B: (a), OT; (b), OE), LDT (C: (a), TL; (b), NT), tail suspension (D), and forced swimming (E) tasks. (F) Effects on hippocampal BDNF expression, and CREB and NF-κB activation. Effects on the infiltration of LPS+/CD11b+ (G) and Iba1+ cells (H) into the hippocampus. Effects on blood corticosterone (CORT, I), IL-6 (J), and LPS levels (K). Mice were exposed to IS and test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days. Normal control group (NC), not exposed to IS, was treated with 1% maltose instead of test agents. Hippocampal p65, p-p65, CREB, p-CREB, BDNF, and β-actin were analyzed by immunoblotting. Blood IL-6, corticosterone, and LPS were assayed by ELISA kits. Iba1+ and LPS+/CD11b+ cells were measured using a confocal microscope. Data values were indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS alone treated group.](https://figures.cochat.ai/paper-figures/f295618ef0d346b6ab344642211ff120/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-2.jpg)
![Figure 3 Oral administration of Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 alleviated immobilization stress (IS)-induced colitis in mice. Effects on the colon length (A), macroscopic score (B), myeloperoxidase (MPO) activity (C), IL-6 (D), IL-1β (E), and COX-2 expression, and NF-κB activation (F). Effects on the infiltration of CD11b+/CD11c+ cells into the colon (G), fecal microbiota composition (H), and fecal LPS levels (I). First, mice were exposed to IS and test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days. Normal control group (NC), not exposed to IS, was treated with 1% maltose instead of test agents. Colonic p65, p-p65, COX-2, and β-actin were analyzed by immunoblotting. CD11b+ and CD11c+ cell populations were assayed using a confocal microscope. Fecal bacteria were assayed by qPCR. Fecal LPS assayed by ELISA kit. Data values are indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS group.](https://figures.cochat.ai/paper-figures/3a3ce012da5a43928f619d4fe82acd97/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-3.jpg)
![Figure 4 Pretreatment with Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 protected IS-induced anxiety and hippocampal inflammation in mice. (A) Procedure. Effects on anxiety-like behaviors in elevated plus maze (B: (a), OT; (b), OE), LDT (C: (a), TL; (b), NT), tail suspension (D), and forced swimming (E) tasks. (F) Effects on hippocampal BDNF expression and CREB and NF-κB activation. Effects on the infiltration of LPS+/CD11b+ (G) and Iba1+ cells (H) into the hippocampus. Effects on blood corticoterone (CORT, I), IL-6 (J), and LPS levels (K). Test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days and IS then exposed to mice. Normal control group (NC), not exposed to IS, were treated with 1% maltose instead of test agents. Hippocampal p65, p-p65, CREB, p-CREB, BDNF, and β-actin were assayed by immunoblotting. Blood corticosterone, IL-6, and LPS were assayed by ELISA kits. Iba1+ and LPS+/CD11b+ cells were measured using a confocal microscope. Data values are indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS group.](https://figures.cochat.ai/paper-figures/3ea3e24b41f3415eb8670cfd52bb7f70/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-4.jpg)
![Figure 5 Pretreatment with Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 protected IS-induced colitis in mice. Effects on colon length (A), macroscopic score (B), colonic myeloperoxidase (MPO) activity (C), IL-6 (D), IL-1β (E), and COX-2 expression and NF-κB activation (F). (G) Effects on the CD11b+/CD11c+ cell infiltration into the colon. Effects on fecal microbiota composition (H) and fecal LPS levels (I). Test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days and IS then exposed to mice. Normal control group (NC), not exposed to IS, were treated with 1% maltose instead of test agents. Colonic p65, p-p65, COX-2, and β-actin were analyzed by immunoblotting. CD11b+ and CD11c+ cells were assayed using a confocal microscope. Fecal bacteria were assayed by qPCR. Fecal LPS were assayed by ELISA kit. Data values are indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS group.](https://figures.cochat.ai/paper-figures/c1e4fc9b795244b2a30511a68364aa22/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“such a treatment decreased the Proteobacteria population and bacterial LPS production in murine gut.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [130]
In the citing paper
“Jang et al. [130] showed that oral administration of the probiotics Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 isolated from healthy human feces suppressed the immobilization stress-induced anxiety and depression in mice.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735 · cited 2×
“However, the fecal transplantation of conventional mice into germ-free mice suppresses anxiety [19].”
BackgroundThe gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
(2015) · PubMed Central · Cited by 2,540
Gut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460 · cited 1×
“The gut microbiota is bidirectionally connected to the brain: Dysfunction of the HPA axis by stressors can cause gut microbiota dysbiosis and psychiatric disorders and probiotics can alleviate anxiety [47,48].”
BackgroundThe role of the gut microbiota in nutrition and health
Flint, H. J., Scott, K. P., Louis, P., & Duncan, S. H. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.156 · Cited by 2,182
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079 · cited 1×
“Anxiety disorder is the most common disorder characterized by somatic, emotional, cognitive, and behavioral components [1,2].”
BackgroundMechanisms of action of probiotics
Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy063 · Cited by 1,423 · cited 1×
“Probiotics, including bifidobacteria and lactobacilli, exhibit a variety of pharmacological activities: They alleviate constipation, diarrhea, imbalanced immune system, and psychiatric disorders [22,23].”
BackgroundKim, K.-A., Gu, W., Lee, I.-A., Joh, E.-H., & Kim, D.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047713 · Cited by 1,176 · cited 1×
“The endotoxin concentrations of feces and blood were assayed, as previously reported [31].”
MethodSelf-citation
Cited by
Items 201–208 of 208
Yang, S., Yang, H., Wang, B., Guo, W., Wang, W., Ding, Y., Wang, W., Xie, X., Ji, Y., Liu, F., et al. (2026) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2595176
Kim, H.-I., Ma, X., Kim, S. M., Yoo, H., & Kim, D. H. (2026) · Journal of Applied Microbiology · doi:10.1093/jambio/lxag144 · Cited by 1
Self-citationWu, S., Shi, X., Chen, X., Ye, Q., Ji, D., & Li, H. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109398
Hou, H., Li, Y., Tang, W., Gao, Y., Tian, Y., Chen, F., Zhang, L., Zhang, J., Xu, X., Li, Y., et al. (2026) · General Psychiatry · doi:10.1002/gps3.70036
“42 65 Probiotics may counteract this cascade by strengthening mucosal barrier integrity and suppressing neuroimmune activation.”
易, 媛. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1682912
Microgliopathy in poststroke depression: exploring mechanisms and therapeutic strategies
Yang, C., Wu, S., Cao, H., Yin, Y., Zhang, Y., Zhang, L., Chen, R., & Tao, X. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.08.046
Anti-hyperuricemia therapy alleviates diet-induced gut inflammation via AhR-IL-22-signalling
Bouquez, S., Campos, P. L., Ottobre, M., & Vega, M. D. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02713-6
“Primer sequences are listed in Supplementary Table S2 [25].”
Jaafari, M., Pajand, O., Saravani, A., Fayyazi, A., Alizadeh, A., Bagheri, N., Razavi, S. S., & Eslami, M. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115502 · Cited by 1
Metadata
- Authors
- Jang, H.-M., Lee, K.-E., & Kim, D.-H.
- Affiliations
- Kyung Hee University (KR)
- Corresponding author
- Kim, Dong-Hyun
- ORCID
- Kim, Dong-Hyun
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-04-11
- Volume
- 11
- Issue
- 4
- Pages
- 819
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6521032
- OpenAlex
- W2939407924
- Cited by
- 208
- References
- 50
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 31 · 2023: 37 · 2022: 33 · 2021: 35 · 2020: 19 · 2019: 8
- FWCI
- 18.33
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (2017R1A5A2014768)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- probiotics, restraint stress, anxiety, depression, colitis, microbiota-gut-brain axis, gut dysbiosis, NF-κB activation, lipopolysaccharide, microglial activation, hippocampus, brain-derived neurotrophic factor, interleukin-6, corticosterone, Proteobacteria, gut immune response
- MeSH terms
- Bifidobacterium adolescentis, Animals, Anxiety, Cell Line, Colitis, Depression, Humans, Lipopolysaccharides, Male, Mice, Inbred C57BL, Neuroblastoma, Restraint, Physical, Stress, Psychological, Tumor Cells, Cultured, NF-kappa B, Microglia, Probiotics, Mice, Limosilactobacillus reuteri, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.